Table II.
Variant | Statistic | COX-2 | Bcl-2 | Bax | IGF1-R | Ki-67 |
---|---|---|---|---|---|---|
COX-2 | Correlation | 1 | 0.138 | 0.113 | 0.191a | 0.029 |
Significance (p) | - | 0.152 | 0.241 | 0.045 | 0.766 | |
Bcl-2 | Correlation | 0.138 | 1 | -0.036 | 0.065 | 0.007 |
Significance (p) | 0.152 | - | 0.712 | 0.497 | 0.940 | |
Bax | Correlation | 0.113 | −0.036 | 1 | −0.055 | −0.019 |
Significance (p) | 0.241 | 0.712 | - | 0.570 | 0.847 | |
IGF1-R | Correlation | 0.191a | 0.065 | −0.055 | 1 | −0.236a |
Significance (p) | 0.045 | 0.497 | 0.570 | - | 0.013 | |
Ki-67 | Correlation | 0.029 | 0.007 | −0.019 | −0.236a | 1 |
Significance (p) | 0.766 | 0.940 | 0.847 | 0.013 | - |
Spearman's correlation showing statistically significant correlations between COX-2 expressed in IDC, with IGF1-R expressed in IDC and DCIS.
P<0.05 denotes statistically significant differences.
IDC, invasive ductal carcinoma; DCIS, ductal carcinoma in situ; IGF1-R, type I insulin-like growth factor receptor.